Literature DB >> 18524824

Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection.

Wei Jiang1, Michael M Lederman, Richard J Mohner, Benigno Rodriguez, Todd M Nedrich, Clifford V Harding, Scott F Sieg.   

Abstract

Toll-like receptor 9 (TLR9) agonists such as unmethylated bacterial CpG DNAs activate B lymphocytes directly, potentially influencing their function and homeostasis. To assess B-cell responsiveness to TLR9 agonists in human immunodeficiency virus (HIV) disease, we examined the ability of naive and memory B cells to proliferation and to increase surface expression of CD80 in response to CpG oligonucleotides (ODN). CpG ODN induced expression of CD80 similarly in B cells from HIV-infected persons and from healthy controls. In contrast, proliferation responses to CpG ODN were markedly impaired in both naive and memory B-cell subsets from HIV-infected persons. Naive B-cell proliferation defects were related to plasma HIV RNA and, among memory B cells, to the frequencies of CD21-negative cells. Importantly, TLR9 mRNA levels were significantly diminished in freshly prepared naive B cells and especially so in memory B cells from HIV-positive viremic donors, suggesting a possible underlying mechanism for the observed functional impairments. Dose-response studies indicated that optimal induction of CD80 expression was achieved with much lower concentrations of CpG ODN than optimal induction of proliferation. We propose that the relatively low threshold of activation that is required for CD80 induction by CpG ODN might explain the preservation of this response in B cells from HIV-infected persons despite diminished TLR9 expression. Impaired responsiveness to TLR9 agonists may contribute to defects in humoral immunity in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524824      PMCID: PMC2519583          DOI: 10.1128/JVI.00660-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.

Authors:  Jihed Chehimi; Donald E Campbell; Livio Azzoni; Darlene Bacheller; Emmanouil Papasavvas; Ghassen Jerandi; Karam Mounzer; Jay Kostman; Giorgio Trinchieri; Luis J Montaner
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

2.  A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.

Authors:  Nadia L Bernasconi; Nobuyuki Onai; Antonio Lanzavecchia
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

3.  The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.

Authors:  Emer Bourke; Daniela Bosisio; Josee Golay; Nadia Polentarutti; Alberto Mantovani
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

4.  Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections.

Authors:  Lukas Hunziker; Mike Recher; Andrew J Macpherson; Adrian Ciurea; Stefan Freigang; Hans Hengartner; Rolf M Zinkernagel
Journal:  Nat Immunol       Date:  2003-03-10       Impact factor: 25.606

5.  Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function.

Authors:  Angela Malaspina; Susan Moir; Shyamasundaran Kottilil; Claire W Hallahan; Linda A Ehler; Shuying Liu; Marie A Planta; Tae-Wook Chun; Anthony S Fauci
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

6.  Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.

Authors:  Hendrik Poeck; Moritz Wagner; Julia Battiany; Simon Rothenfusser; Daniela Wellisch; Veit Hornung; Bernd Jahrsdorfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

7.  CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.

Authors:  Natalia Teleshova; Jessica Kenney; Jennifer Jones; Jason Marshall; Gary Van Nest; Jason Dufour; Rudolf Bohm; Jeffrey D Lifson; Agegnehu Gettie; Melissa Pope
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

8.  CpG oligodeoxynucleotides improve the response to hepatitis B immunization in healthy and SIV-infected rhesus macaques.

Authors:  Daniela Verthelyi; Vivian W Wang; Jeffrey D Lifson; Dennis M Klinman
Journal:  AIDS       Date:  2004-04-30       Impact factor: 4.177

9.  Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection.

Authors:  Angelo De Milito; Anna Nilsson; Kehmia Titanji; Rigmor Thorstensson; Elisabet Reizenstein; Mitsuo Narita; Sven Grutzmeier; Anders Sönnerborg; Francesca Chiodi
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

10.  Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.

Authors:  Susan Moir; Angela Malaspina; Jason Ho; Wei Wang; Angela C Dipoto; Marie A O'Shea; Gregg Roby; Joann M Mican; Shyam Kottilil; Tae-Wook Chun; Michael A Proschan; Anthony S Fauci
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

View more
  22 in total

Review 1.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation.

Authors:  Lindsay K Nicholson; Harsh Pratap; Elisabeth Bowers; Elise Gunzburger; Srinivasa R Bandi; Edward M Gardner; Brent E Palmer; Timothy Wright; John Kittelson; Edward N Janoff
Journal:  Immunobiology       Date:  2018-09-07       Impact factor: 3.144

3.  Alterations in peripheral blood B-cell populations in SHIV89.6P-infected macaques (Macacca fascicularis).

Authors:  Heather M Kling; Timothy W Shipley; Karen A Norris
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

4.  Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.

Authors:  Myron J Levin; Anna-Barbara Moscicki; Lin-Ye Song; Terrence Fenton; William A Meyer; Jennifer S Read; Edward L Handelsman; Barbara Nowak; Carlos A Sattler; Alfred Saah; David R Radley; Mark T Esser; Adriana Weinberg
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

5.  Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.

Authors:  Stefanie Weber; Barbara Weiser; Kimdar S Kemal; Harold Burger; Christina M Ramirez; Klaus Korn; Kathryn Anastos; Rupert Kaul; Colin Kovacs; Walter Doerfler
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

Review 6.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

7.  Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis.

Authors:  Julien van Grevenynghe; Rafael A Cubas; Alessandra Noto; Sandrina DaFonseca; Zhong He; Yoav Peretz; Abdelali Filali-Mouhim; Franck P Dupuy; Francesco A Procopio; Nicolas Chomont; Robert S Balderas; Elias A Said; Mohamed-Rachid Boulassel; Cecile L Tremblay; Jean-Pierre Routy; Rafick-Pierre Sékaly; Elias K Haddad
Journal:  J Clin Invest       Date:  2011-09-19       Impact factor: 14.808

8.  Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment.

Authors:  Adriana Weinberg; Sharon Huang; Terence Fenton; Julie Patterson-Bartlett; Philimon Gona; Jennifer S Read; Wayne M Dankner; Sharon Nachman
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

9.  Antigen receptor signals rescue B cells from TLR tolerance.

Authors:  Jayakumar S Poovassery; Tony J Vanden Bush; Gail A Bishop
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

10.  Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

Authors:  Samuel O Pine; M Juliana McElrath; Pierre-Yves Bochud
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.